Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Tips from these results
Recent Share tips:
- Avoid Quiz (QUIZ) by Steve Moore in ShareProphets
- Buy Golden Prospect Precious Metals Ltd. (GPM) by Tom Winnifrith in N50
- Buy Golden Prospect Precious Metals Ltd. (GPM) by Tom Winnifrith in Hot Stock Rockets
- Buy BP (BP.) by Tom Winnifrith in ShareProphets
- Buy Tesco (TSCO) by Cliff D'Arcy in The Motley Fool
- Buy Golden Prospect Precious Metals Ltd. (GPM) by Nigel Somerville in Five Free Share Tips
- Long Term Buy The Mission Group (TMG) by Kevin Godbold in The Motley Fool
- Buy Barclays (BARC) by Rupert Hargreaves in The Motley Fool
- Risky Buy Argo Blockchain (ARB) by Rupert Hargreaves in The Motley Fool
- Long Term Buy Admiral Group (ADM) by Rupert Hargreaves in The Motley Fool
- Watch Sosandar (SOS) by Nigel Somerville in ShareProphets
- Avoid Dignity (DTY) by Chris Bailey in ShareProphets
- Sell Corero Network Security (CNS) by Steve Moore in ShareProphets
- Buy Diageo (DGE) by Edward Sheldon in The Motley Fool
- Buy Smith & Nephew (SN.) by Edward Sheldon in The Motley Fool
- Buy Tesco (TSCO) by Paul Summers in The Motley Fool
- Buy Johnson Matthey (JMAT) by Malcolm Stacey in ShareProphets
- Buy Golden Prospect Precious Metals Ltd. (GPM) by Nigel Somerville in ShareProphets
- Hold Carnival (CCL) by Richard Evans in The Telegraph - Questor
- Buy Croda International (CRDA) by Josephine Moulds in The Times - Tempus
Vectura Group (VEC)
Health Care Sector
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
Vectura Group Overview
Vectura develops inhaled therapies principally for the treatment of respiratory diseases. Inhaled formulation development is increasingly complex with a wide variety of small molecules and biologics, increasing use of combination products and the need for targeted lung delivery or deep lung deposition for systemic delivery. We offer formulation services for DPI, pMDI and nebuliser development, including small molecules and biologics, complex combinations and generic products.Latest Vectura Group Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | JP Morgan | – | 2021-03-19 07:30:00 19/03/2021 | – |
| – | Citi | – | 2021-01-22 09:15:00 22/01/2021 | – |
| – | JP Morgan | – | 2020-09-23 09:00:00 23/09/2020 | – |
| – | Kevin Godbold | – | 2020-09-15 12:10:00 15/09/2020 | – |
| – | Peel Hunt | – | 2020-07-30 08:50:00 30/07/2020 | – |
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
Vectura Group Overview
Vectura develops inhaled therapies principally for the treatment of respiratory diseases. Inhaled formulation development is increasingly complex with a wide variety of small molecules and biologics, increasing use of combination products and the need for targeted lung delivery or deep lung deposition for systemic delivery. We offer formulation services for DPI, pMDI and nebuliser development, including small molecules and biologics, complex combinations and generic products.Latest Vectura Group Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | JP Morgan | – | 2021-03-19 07:30:00 19/03/2021 | – |
| – | Citi | – | 2021-01-22 09:15:00 22/01/2021 | – |
| – | JP Morgan | – | 2020-09-23 09:00:00 23/09/2020 | – |
| – | Kevin Godbold | – | 2020-09-15 12:10:00 15/09/2020 | – |
| – | Peel Hunt | – | 2020-07-30 08:50:00 30/07/2020 | – |